查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1526323

全球生物晶片市場

Biochips
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 369 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到2030年全球生物晶片市場將達到448億美元

2023年全球生物晶片市場預計為193億美元，預計到2030年將達到448億美元，2023年至2030年複合年成長率為12.8%。 DNA 晶片是本報告分析的細分市場之一，預計複合年成長率為 11.6%，到分析期結束時將達到 147 億美元。在分析期間，實驗室晶片產業的複合年成長率預計為 13.4%。

美國市場預計70億美元，中國預計複合年成長率14.8%

預計2023年美國生物晶片市場規模將達70億美元。中國作為世界第二大經濟體，預計2030年市場規模將達42億美元，2023-2030年分析期間複合年成長率為14.8%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 10.7% 和 11.3%。在歐洲，德國的複合年成長率預計約為 12.5%。

全球生物晶片市場 - 主要趨勢和促進因素總結

生物晶片是微型實驗室，可以同時進行數百或數千個生化反應，在醫學診斷、基因組學和藥物開發等各個領域提供了巨大的潛力。這些小型設備通常由矽或玻璃基板製成，整合了微陣列和微流體，可以高精度和快速分析生物材料。生物晶片可以分析 DNA、RNA、蛋白質和小分子，使其成為基因序列測定、基因表現和生物標記檢測的重要工具。在臨床診斷中，生物晶片透過識別特定的遺傳標記和病原體，實現快速、準確的疾病檢測，促進早期診斷和個人化治療計劃。高效且經濟高效地進行大規模篩檢的能力徹底改變了生物醫學研究和臨床實踐。

技術進步顯著提高了生物晶片的功能和應用。微加工技術的創新促進了更先進、更靈敏的生物晶片的發展，甚至可以檢測微量的生物物質。先進感測器和成像系統與生物晶片的整合提高了分析性能，實現即時監測和高通量分析。此外，隨著實驗室晶片技術的出現，將所有測試功能小型化並整合到單一晶片上，生物晶片的應用範圍已從傳統實驗室擴展到包括照護現場診斷和現場應用。該技術可以對樣本進行快速現場分析，在資源有限的環境和即時疾病爆發監測中特別有用。

生物晶片市場的成長受到多種因素的推動。慢性病和感染疾病的日益普及增加了對先進診斷工具的需求，並增加了生物晶片在臨床實踐中的採用。生物晶片擴大用於開發治療多種癌症的個人化標靶藥物。消費者對維持健康生活方式的興趣日益濃厚也推動了對晶片的需求。微陣列和微射流技術的進步正在提高效率和精度，促進其在基因組學和蛋白​​質組學研究中的應用。對個人化醫療的日益關注以及對準確、快速診斷解決方案的需求也是重要的促進因素，因為生物晶片提供了根據個人基因圖譜客製化治療的能力。此外，支持基因組研究和先進診斷技術發展的政府資助和舉措也推動了市場成長。生物晶片在環境監測、食品安全檢測和生物恐怖主義檢測等領域的廣泛應用為其使用開闢了新途徑，並進一步推動市場擴張。這些因素綜合在一起，使得生物晶片市場充滿活力並快速成長，為生物技術領域的創新和市場開拓創造了巨大的機會。

受訪企業範例（知名企業總合69家）

  • Eppendorf AG
  • Fluidigm Corporation
  • F. Hoffmann-La Roche AG
  • IntegraGen SA
  • Agendia NV
  • Ocimum Biosolutions Ltd.
  • Analis SA/NV
  • Empire Genomics LLC
  • Mobidiag
  • AVIVA BioSciences Corporation
  • Little Things Factory GmbH
  • IDEX Health & Science LLC
  • Arround Inc.
  • As One Corporation
  • Cala Del Forte

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 拉丁美洲
  • 世界其他地區

第4章 比賽

簡介目錄
Product Code: MCP-1026

Global Biochips Market to Reach US$44.8 Billion by 2030

The global market for Biochips estimated at US$19.3 Billion in the year 2023, is expected to reach US$44.8 Billion by 2030, growing at a CAGR of 12.8% over the analysis period 2023-2030. DNA Chip, one of the segments analyzed in the report, is expected to record a 11.6% CAGR and reach US$14.7 Billion by the end of the analysis period. Growth in the Lab-on-a-Chip segment is estimated at 13.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$7.0 Billion While China is Forecast to Grow at 14.8% CAGR

The Biochips market in the U.S. is estimated at US$7.0 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$4.2 Billion by the year 2030 trailing a CAGR of 14.8% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 10.7% and 11.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 12.5% CAGR.

Global Biochips Market - Key Trends & Drivers Summarized

Biochips are miniature laboratories that can perform hundreds or thousands of simultaneous biochemical reactions, offering vast potential in various fields such as medical diagnostics, genomics, and drug development. These tiny devices, typically fabricated from silicon or glass substrates, integrate microarrays and microfluidics to analyze biological materials with high precision and speed. Biochips can analyze DNA, RNA, proteins, and small molecules, making them essential tools in genetic sequencing, gene expression profiling, and biomarker detection. In clinical diagnostics, biochips enable rapid and accurate detection of diseases by identifying specific genetic markers or pathogens, thus facilitating early diagnosis and personalized treatment plans. Their ability to conduct large-scale screenings efficiently and cost-effectively has revolutionized biomedical research and clinical practices.

Technological advancements have significantly enhanced the capabilities and applications of biochips. Innovations in microfabrication techniques have led to the development of more sophisticated and sensitive biochips, capable of detecting even minute quantities of biological substances. The integration of advanced sensors and imaging systems with biochips has improved their analytical performance, enabling real-time monitoring and high-throughput analysis. Additionally, the advent of lab-on-a-chip technology, which miniaturizes and integrates all laboratory functions on a single chip, has expanded the application scope of biochips beyond traditional research labs to point-of-care diagnostics and field applications. This technology allows for the rapid, on-site analysis of samples, which is particularly beneficial in resource-limited settings and for real-time disease outbreak monitoring.

The growth in the biochips market is driven by several factors. The increasing prevalence of chronic and infectious diseases has heightened the demand for advanced diagnostic tools, propelling the adoption of biochips in clinical settings. Biochips are being increasingly used in the development of personalized and targeted drugs for treating various cancers. Increasing interest among consumers in maintaining healthy lifestyles has also been resulting in demand growth for the chips.  Technological advancements in microarray and microfluidics technology are enhancing the efficiency and accuracy of biochips, encouraging their widespread use in genomics and proteomics research. The rising focus on personalized medicine and the need for precise and rapid diagnostic solutions are also significant drivers, as biochips offer the capability to tailor treatments based on individual genetic profiles. Furthermore, government funding and initiatives supporting genomics research and the development of advanced diagnostic technologies are boosting market growth. The expanding applications of biochips in environmental monitoring, food safety testing, and bioterrorism detection are opening new avenues for their use, further driving market expansion. Together, these factors are fostering a dynamic and rapidly growing market for biochips, presenting significant opportunities for innovation and development in the field of biotechnology.

Select Competitors (Total 69 Featured) -

  • Eppendorf AG
  • Fluidigm Corporation
  • F. Hoffmann-La Roche AG
  • IntegraGen SA
  • Agendia NV
  • Ocimum Biosolutions Ltd.
  • Analis SA/NV
  • Empire Genomics LLC
  • Mobidiag
  • AVIVA BioSciences Corporation
  • Little Things Factory GmbH
  • IDEX Health & Science LLC
  • Arround Inc.
  • As One Corporation
  • Cala Del Forte

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Biochips - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Biochips: A Primer
    • Manufacturing Systems Used in Biochip Manufacture
    • Historical Perspective
    • Classification of Biochips
    • Application Markets
    • Market Outlook
    • Protein Biochips Set for Expansion
    • Recent Technological Advancements Drive Wider Adoption of Biochips
    • Competition
    • Biotech Startups Pose Competition
    • Recent Market Activity
    • World Brands
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Biochips Seek Increasing Role in POC Testing
    • Biochips to Help Next-Generation Sequencing Scale New Heights & Unravel Intimidating Biological Problems
    • Research Forays into Organ-On-A-Chip (OOC)
    • OCC Start-Ups Enter the Fray
    • Select Organ-On-A-Chip Start-Ups & Their Specialties
    • Biochip Implants Set to Make Big Gains
    • Biochips Aid in Alleviating Issues Associated with Immunological Studies
    • Challenges for Widespread Adoption
    • Drug Discovery Applications to Drive Market
    • Growing Preference for DNA/Protein Biochips in Personalized Medicine
    • Global Personalized Medicine Market: Revenues in US$ Million for the Years 2019, 2021, 2023 and 2025
    • Microphysiological Systems to Take Personalized Medicine Much Farther
    • Biochip Array Technology Enables Reliable and Accurate Investigation of Metabolic Syndrome
    • Proteomics and Genomics Drive Opportunities for Biochips
    • Increasing Application of Genomics and Proteomics in Cancer Diagnostics and Treatment to Drive Growth
    • Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
    • Potential Application of Biochips in Diabetes Diagnosis and Management Unfurl New Growth Opportunities
    • World Diabetes and Population Statistics (2019, 2030 & 2045)
    • Rise in Infectious Diseases and Need for High-Troughput Diagnosis Drive Interest in Biochips
    • Infectious Diseases Related Mortality High Among Children Below 5 Years: Breakdown of Leading Causes of Death in Children Below 5 Years (in %)
    • Global Number of Deaths Caused Due to Communicable Diseases (In 000s)
    • Agriculture Sector: Niche Vertical
    • Development of Protein Microarrays for the Field of Diagnostics: Key Challenges
    • Biochip Industry Thrives on Innovation
    • Researchers at UCI Develop Machine Learning-Assisted Biochip
    • New Biochip Combines Nanoparticle Printing and AI for Tumor Analysis
    • Axbio Introduces Smartbiochip
    • Multi-Dimensional Printing Technology Enables Development of New Biochip Printing Technique
    • MIT Develops Neuromorphic Chip Capable of Mimicking Human Brain
    • Biochips from AYOXXA: A Giant Leap in Protein Multiplexing
    • Biochip Innovations in Drug Discovery Applications
    • Industry Challenges
    • Standardization: A Key Challenge
    • High Costs Restrain Growth
    • Precise Protein Detection: A Challenge
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for DNA Chip by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for DNA Chip by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for DNA Chip by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Lab-on-a-Chip by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Lab-on-a-Chip by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Lab-on-a-Chip by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Protein Chip by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Protein Chip by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Protein Chip by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Drug Discovery & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Drug Discovery & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Drug Discovery & Development by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Disease Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Disease Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Disease Diagnostics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Genomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Genomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Genomics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Proteomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Proteomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for Proteomics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2024 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Agriculture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Agriculture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 27: World 16-Year Perspective for Agriculture by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2024 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 30: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2024 & 2030
    • TABLE 31: World Biochips Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Biochips by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Biochips by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: World 16-Year Perspective for Biochips by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Biochips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2014, 2024 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2014, 2024 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2014, 2024 & 2030
  • JAPAN
    • Biochips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2014, 2024 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2014, 2024 & 2030
  • CHINA
    • Biochips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 53: China Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: China 16-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2014, 2024 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: China 16-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2014, 2024 & 2030
  • EUROPE
    • Biochips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2014, 2024 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Biochips by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Biochips by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Biochips by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
  • FRANCE
    • Biochips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 68: France Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: France 16-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2014, 2024 & 2030
    • TABLE 71: France Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: France 16-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2014, 2024 & 2030
  • GERMANY
    • Biochips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Germany 16-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2014, 2024 & 2030
    • TABLE 77: Germany Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Germany Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Germany 16-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Italy 16-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2014, 2024 & 2030
    • TABLE 83: Italy Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Italy Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Italy 16-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Biochips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 86: UK Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: UK 16-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2014, 2024 & 2030
    • TABLE 89: UK Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: UK Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: UK 16-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 92: Spain Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Spain Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Spain 16-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2014, 2024 & 2030
    • TABLE 95: Spain Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Spain Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Spain 16-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 98: Russia Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Russia Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Russia 16-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2014, 2024 & 2030
    • TABLE 101: Russia Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Russia Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Russia 16-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Rest of Europe Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Rest of Europe 16-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2014, 2024 & 2030
    • TABLE 107: Rest of Europe Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Rest of Europe Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Rest of Europe 16-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Biochips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Asia-Pacific 16-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2014, 2024 & 2030
    • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Asia-Pacific Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Asia-Pacific 16-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Biochips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 116: Latin America Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Latin America Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: Latin America 16-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2014, 2024 & 2030
    • TABLE 119: Latin America Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Latin America Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: Latin America 16-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 122: Rest of World Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Rest of World Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Rest of World 16-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2014, 2024 & 2030
    • TABLE 125: Rest of World Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of World Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of World 16-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2014, 2024 & 2030

IV. COMPETITION